admin

A former Commodity Futures Trading Commission chairman is calling for more regulation of stablecoins, or cryptocurrencies created to be pegged to other assets like fiat money. Timothy Massad, who led the commission during much of the Obama administration’s second term, told CNBC’s Jim Cramer that investors would benefit from more transparency in the wake of
0 Comments
SELINSGROVE, PENNSYLVANIA, UNITED STATES – 2021/01/27: A woman walks past the GameStop store inside the Susquehanna Valley Mall. An online group sent share prices of GameStop (GME) and AMC Entertainment Holdings Inc. (AMC) soaring in an attempt to squeeze short sellers. Photo by Paul Weaver/SOPA Images/LightRocket via Getty Images GameStop sales rose 25% in the
0 Comments
Most people want to forget this part of the 1970s. But inflation is back, and investor Peter Boockvar predicts it will be the most widespread in decades. “Monetary policy … is right now impotent in its ability to stimulate economic activity,” the Bleakley Advisory Group chief investment officer told CNBC’s “Trading Nation” on Wednesday. Boockvar
0 Comments
As Wisconsin legislators work to finalize the state budget for the fiscal year (FY) 2022-23 biennium that begins July 1, the Wisconsin Legislative Fiscal Bureau (LFB) on Tuesday reported the state has substantially more revenue to work with than was anticipated when the LFB issued revenue projections earlier this year. Specifically, the LFB’s revised three-year
0 Comments
In this article WFC CLNE RIDE The Lordstown Motors Corp. Endurance electric pickup truck sits on stage during an unveiling event in Lordstown, Ohio, U.S., on Thursday, June 25, 2020. Matthew Hatcher | Bloomberg | Getty Images Check out the companies making headlines in midday trading. Clean Energy Fuels — Shares of Clean Energy Fuels
0 Comments
A patient suffering from COVID-19 receives treatment at the coronavirus disease (COVID-19) Intensive Care Unit (ICU) of the “Klinikum Darmstadt” clinic in Darmstadt, Germany, May 20, 2021. Kai Pfaffenbach | Reuters LONDON — The cheap and widely-available drug aspirin does not improve survival for patients hospitalized with Covid-19, a U.K. study has found. Oxford University
0 Comments